Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection

Antimicrobial Agents and Chemotherapy
George R CathcartBrian Walker

Abstract

Pseudomonas elastase (LasB), a metalloprotease virulence factor, is known to play a pivotal role in pseudomonal infection. LasB is secreted at the site of infection, where it exerts a proteolytic action that spans from broad tissue destruction to subtle action on components of the host immune system. The former enhances invasiveness by liberating nutrients for continued growth, while the latter exerts an immunomodulatory effect, manipulating the normal immune response. In addition to the extracellular effects of secreted LasB, it also acts within the bacterial cell to trigger the intracellular pathway that initiates growth as a bacterial biofilm. The key role of LasB in pseudomonal virulence makes it a potential target for the development of an inhibitor as an antimicrobial agent. The concept of inhibition of virulence is a recently established antimicrobial strategy, and such agents have been termed "second-generation" antibiotics. This approach holds promise in that it seeks to attenuate virulence processes without bactericidal action and, hence, without selection pressure for the emergence of resistant strains. A potent inhibitor of LasB, N-mercaptoacetyl-Phe-Tyr-amide (K(i) = 41 nM) has been developed, and its ability to bl...Continue Reading

References

Jun 1, 1992·The Journal of Veterinary Medical Science·Y TamuraM Nakamura
Nov 1, 1990·Antimicrobial Agents and Chemotherapy·F R BurnsJ T Wells
Oct 1, 1990·Infection and Immunity·S S PedersenNiels Høiby
Nov 1, 1974·The Journal of Infectious Diseases·P V Liu
Apr 1, 1966·Archives of Biochemistry and Biophysics·K Morihara, H Tsuzuki
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·P A SuciG G Geesey
May 1, 1996·The Journal of Investigative Dermatology·M WeckrothY T Konttinen
Mar 4, 2000·Journal of Microbiological Methods·S StepanovicM Svabic-Vlahovic
Mar 7, 2000·Combinatorial Chemistry & High Throughput Screening·J F LynasD A Owen
Mar 10, 2000·Biochimica Et Biophysica Acta·J Travis, J Potempa
Apr 11, 2000·Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery·P CosmoS O Wikström
Aug 23, 2000·Acta Dermato-venereologica·Artur Schmidtchen
Jun 1, 2001·Toxicon : Official Journal of the International Society on Toxinology·Y KomoriT Nikai
Jun 12, 2001·Methods in Enzymology·J F PoschetV Deretic
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·C CampanacC Roques
Jul 12, 2002·Medicinal Research Reviews·Claudiu T SupuranBrian W Clare
Jul 16, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Kevin G LeidalGerene M Denning
Oct 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Algirdas J JesaitisZbigniew Lewandowski
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Niels Høiby
Feb 8, 2005·American Journal of Respiratory and Critical Care Medicine·Ruxana T SadikotAlice S Prince
Feb 12, 2005·American Journal of Respiratory Cell and Molecular Biology·Sophie DulonMichel Chignard
Nov 23, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jeff G LeidAlyssa K Jeffers
Dec 27, 2005·Journal of Structural Biology·Olayiwola A AdekoyaIngebrigt Sylte
Oct 20, 2006·The European Respiratory Journal·M GrieseD Hartl
Dec 13, 2006·Nature Reviews. Drug Discovery·Lynn L Silver
Feb 7, 2008·Chest·Arnon ElizurThomas W Ferkol
Apr 9, 2008·The International Journal of Biochemistry & Cell Biology·Judith A VoynowShuo Zheng
Aug 23, 2008·Science·David A RaskoVanessa Sperandio
Sep 24, 2009·Bioorganic & Medicinal Chemistry Letters·George R CathcartBrian Walker
Nov 1, 1938·The Journal of Hygiene·A A MilesJ O Irwin

Citations

Feb 19, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W E KamanF J Bikker
Mar 6, 2013·Expert Review of Anti-infective Therapy·Jack N PendletonBrendan F Gilmore
Jan 26, 2016·Journal of Medicinal Chemistry·Stefanie WagnerAlexander Titz
Apr 25, 2015·Chemistry & Biology·Roberta J Melander, Christian Melander
Dec 8, 2015·European Journal of Medicinal Chemistry·Stian SjøliOlayiwola A Adekoya
May 8, 2015·Virulence·Sónia Gonçalves PereiraOlga Cardoso
Aug 16, 2014·International Journal of Medical Microbiology : IJMM·Lívia V SilvaAndré L S Santos
Jun 8, 2012·Environmental Microbiology·Roberto A Bobadilla FazziniVitor A P Martins sos Santos
Apr 14, 2012·Molecular Microbiology·F Heath Damron, Joanna B Goldberg
Apr 9, 2015·Nature Reviews. Microbiology·Ana L Flores-MirelesScott J Hultgren
Nov 25, 2014·The Journal of Antimicrobial Chemotherapy·Venkata Saran SolletiAbdelwahab Omri
Oct 11, 2016·Chemical Communications : Chem Comm·Dávid SzamosváriThomas Böttcher
May 19, 2012·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Marcelo B AntunesNoam A Cohen
Nov 9, 2018·The Journal of Pharmacy and Pharmacology·Michaela EisenhardtFrank Runkel
Jul 19, 2017·Microbiome·Nicholas A BeKasthuri Venkateswaran
Oct 28, 2019·Frontiers in Microbiology·Daniel LoarcaRodolfo García-Contreras
Nov 17, 2020·Frontiers in Microbiology·Sivasamy SethupathyJintae Lee
Mar 7, 2021·Drug Discovery Today·Martin Everett, David T Davies

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.